25.8.16

Pfizer to acquire oncology specialist Medivation for $ 14 bn

Pfizer to acquire oncology specialist Medivation for $ 14 bn


American global pharmaceutical major Pfizer Inc has entered into an agreement to acquire Medivation Inc, a biopharmaceutical company focused on developing and commercialising small molecules for oncology, for a total enterprise value of approximately $ 14 billion.

The merger will give a boost to Pfizer’s consolidation effort through a series of acquisitions, especially after its bid to take over Allergan Plc in a $150 billion deal late last year fell apart when the Obama administration prevented the proposed combination with new rules.

So let's do:
1. Pfizer to acquire oncology specialist Medivation for ____. 

Share this

0 Comment to "Pfizer to acquire oncology specialist Medivation for $ 14 bn"

Post a Comment

News (1270) Jobs (1232) PrivateJobs (317) Events (302) Result (127) Admit (103) Success_Story (65) BankJobs (56) Articles (32) Startups (17) Walk-INS (3)